Announcements
- Result of AGM
- Holding(s) in Company
- Notice of AGM & Annual Report & Accounts
- Final Results
- Realisation-c£1.5m on sale of shares in Incanthera
- IMMUPHARMA AT BIO-EQUITY 2024 12-14 May
- Grant of Share Options
- New intellectual property strategy initiated
- Incanthera provides Comm'l Update/Revenue F'casts
- Grant of Share Options
More ▼
Key statistics
On Monday, ImmuPharma PLC (25I:FRA) closed at 0.0185, 9,150.00% above the 52 week low of 0.0002 set on Feb 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0185 |
---|---|
High | 0.0185 |
Low | 0.0185 |
Bid | 0.015 |
Offer | 0.0425 |
Previous close | 0.0185 |
Average volume | 0.00 |
---|---|
Shares outstanding | 416.44m |
Free float | 237.37m |
P/E (TTM) | -- |
Market cap | 7.71m GBP |
EPS (TTM) | -0.0081 GBP |
Data delayed at least 15 minutes, as of Jul 22 2024 11:13 BST.
More ▼